Patients should be advised to: Inspect feet daily for injuries, blisters, or colour changes Wear well-fitting footwear and avoid walking barefoot Maintain good foot hygiene and moisturise dry skin (avoiding between toes) Seek same-day assessment by the multidisciplinary foot care service for any new foot wounds, signs of infection, or sudden changes in foot shape Attend annual diabetes reviews incorporating the Nine Care Processes, including foot screening Referral to specialist services is appropriate when: Neuropathic pain remains inadequately controlled despite optimised primary care management Diagnostic uncertainty exists regarding neuropathy aetiology, or features are atypical or rapidly progressive Foot ulceration, infection, or suspected Charcot arthropathy develops (same-day referral to multidisciplinary foot care service per NICE NG19) Severe infection or critical limb ischaemia (emergency hospital admission) Severe autonomic symptoms significantly impair quality of life Patient engagement through diabetes self-management education empowers individuals to optimise lifestyle factors including diet, physical activity, and smoking cessationall contributing to improved metabolic control and reduced complication risk
This innovation could particularly benefit older adults and patients with mobility challenges who struggle with frequent injections
This is why Phase 3 TRIUMPH protocols allow dose reduction rather than discontinuation when a participant approaches a low BMI
BPC-157 peptide : A popular synthetic peptide believed to aid in healing
Collagen protein, despite its popularity, is NOT a complete protein and should never serve as your primary source
Rare but severe complications, including bowel obstruction, have also been reported, raising important safety considerations [4,6,7]
